A unique manifestation of Langerhans cell histiocytosis: Diagnostic and therapeutic considerations of atypical cases | Ear, Nose & Throat Journal Skip to content Skip to navigation

A unique manifestation of Langerhans cell histiocytosis: Diagnostic and therapeutic considerations of atypical cases

| Reprints
April 30, 2018
by Judit Kálmán, MD; Tamás Horváth, MD, PhD; Bálint Liktor, MD; Balázs Liktor, MD, PhD

Abstract

Langerhans cell histiocytosis (LCH) is regarded as a clonal disease, usually carrying the activating BRAF mutation V600E. Although LCH theoretically may affect all types of human tissue and typically appears during childhood, temporal bone involvement in adult patients is exceedingly rare. We report an atypical case of a 56-year-old man as one of the oldest patients diagnosed with temporal bone involvement of a BRAF-negative LCH, which caused painless otorrhea and hearing loss. Cutaneous manifestation (multifocal multisystem LCH, also known as Letterer-Siwe disease) was later recognized incidentally. Administration of ifosfamide plus doxorubicin and mesna with supplementary irradiation resulted in a temporary remission followed by slow but constant tumor progression, which after 2.5 years became resistant to treatment with cytarabine and dasatinib. Attempts at therapy (cladribine) to achieve cure are ongoing.

ENT Journal provides full text articles to our registered members.
Please log in or sign up for a FREE membership to view the full content:

You may also like to: